论文部分内容阅读
目的:探讨临床路径在肺炎支原体肺炎中的应用价值。方法:将126例肺炎支原体肺炎患者随机分为路径组和非路径组,路径组61例按临床路径表由医护人员有计划地从入院到出院给予诊疗及护理服务;非路径组57例采用传统的诊疗护理方式诊疗。结果:路径组患者平均住院天数及平均住院费用均明显低于非路径组,且健康教育知晓率及服务满意度均明显高于非路径组,两组上述观察指标差异均有统计学意义(P<0.05)。结论:临床路径可缩短肺炎支原体肺炎患者的住院天数、控制住院费用、同时能提升患方健康教育知晓率及服务满意度。
Objective: To investigate the clinical value of Mycoplasma pneumoniae in clinical pathology. Methods: 126 cases of Mycoplasma pneumoniae pneumonia patients were randomly divided into path group and non-path group, the path group of 61 cases according to the clinical pathway table by the medical staff from hospital to hospital for treatment and care planning; 57 cases of non-pathological group using the traditional Diagnosis and treatment of care treatment. Results: The average length of hospital stay and average hospitalization cost in path group were significantly lower than those in non-path group, and the awareness of health education and service satisfaction were significantly higher than those in non-path group (P <0.05). Conclusion: The clinical pathway can shorten the length of hospital stay of patients with Mycoplasma pneumoniae pneumonia, control the hospitalization expenses, and improve the health education awareness and service satisfaction of patients.